These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1659463

  • 1. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.
    Sánchez Crespo M, Fernández-Gallardo S.
    J Lipid Mediat; 1991; 4(2):127-43. PubMed ID: 1659463
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z, Imura Y, Nishikawa K, Sumida S.
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO, Bensard DD, Harken AH.
    Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
    [Abstract] [Full Text] [Related]

  • 6. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
    Hwang SB.
    J Lipid Mediat; 1990 May; 2(3-4):123-58. PubMed ID: 1966805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet and plasma platelet-activating factor in sepsis and myocardial infarction.
    Graham RM, Strahan ME, Norman KW, Watkins DN, Sturm MJ, Taylor RR.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):167-82. PubMed ID: 8012763
    [Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994 Mar; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 10. Recent studies on icosanoids and PAF-acether modulation of some central neurosecretions in the rat.
    Dray F, Gerozissis K, Fafeur V, Wisner A, Bommelaer-Bayet MC, Saadi M, Rougeot C, Tiberghien C, Junier MP.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Mar; 19():383-6. PubMed ID: 2546391
    [No Abstract] [Full Text] [Related]

  • 11. [Platelet activating factor--role in regulating the functional activity of the mononuclear phagocyte system].
    Shebzukhov IuV, Mysiakin EB.
    Vopr Med Khim; 1996 Mar; 42(4):278-83. PubMed ID: 9254510
    [Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor (PAF) and blastocyst-endometrial interactions.
    Harper MJ, Kudolo GB, Alecozay AA, Jones MA.
    Prog Clin Biol Res; 1989 Mar; 294():305-15. PubMed ID: 2542988
    [No Abstract] [Full Text] [Related]

  • 13. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 14. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM, Kulikov VI, Manevich EM, Muliar AG, Shvets VI.
    Farmakol Toksikol; 1988 Mar; 51(4):113-23. PubMed ID: 2847936
    [No Abstract] [Full Text] [Related]

  • 15. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
    Lopez Diez F, Nieto ML, Fernandez-Gallardo S, Gijon MA, Sanchez Crespo M.
    J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE.
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A, Paul AK, Shukla SD.
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
    Dichmann S, Rheinen H, Panther E, Herouy Y, Czech W, Termeer C, Simon JC, Gebicke-Haerter PJ, Norgauer J.
    J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009
    [Abstract] [Full Text] [Related]

  • 20. Human corneal epithelial cell functional responses to inflammatory agents and their antagonists.
    Sharif NA, Wiernas TK, Howe WE, Griffin BW, Offord EA, Pfeifer AM.
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2562-71. PubMed ID: 9856766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.